Data Integrity Risk Management for Life Sciences Companies


This practice note addresses key topics related to the management of data by drug, biologic, and medical device companies whose products are regulated by the U.S. Food and Drug Administration (FDA). This includes strategies for identifying potential data integrity compliance gaps and questions to ask drug, biologic, medical device, and other life sciences clients.